Adis, a Wolters Kluwer business, has announced a new tiered pricing model for institutions subscribing to its leading pharmacology titles in 2010. The new tiered pricing model is designed to make Adis’ publications more affordable for their recession-hit customers.
The new model offers 3 tiers of pricing which will deliver significantly lower prices for small and mid-sized organisations and a price freeze for the largest organisations. The model is based on the number of FTEs within pharmaceutical companies, the number of staffed beds in hospitals; and the number of relevant FTE across health faculties across academic institutions.
Adis journals are projected to be a must-have resource for anyone with an interest in independent reviews and original research to support better therapeutic decisions. The portfolio features many leading titles on drug development, therapy and pharma co-evaluation including Drugs, PharmacoEconomics and Drug Safety.
Search for more such market pricing in K-Store
Discuss this NEWS
Licensing, Pricing and Contracts
More News in this Theme